Company / Assets per Share
Theravance Biopharma, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.82
FY2025
5-year range
$5.83 / $9.82
FY2021-FY2025
Trend
+33.3%
vs FY2024
Sector context
#101 of 210
Health Care
What the data says
At $9.82, Theravance Biopharma, Inc.'s assets per share ranks #101 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $5.83 in FY2021 to $16.83 in FY2016.
Based on SEC 10-K filings.
9.82 in FY2025 with a 5-year CAGR of +3.6%.
Improved from $5.86 to $9.82 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#101 of 210 in Health CareTop 48% of 210This company $9.82 Sector average $353.15
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 33.3% year-over-year.
- Ranks #101 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.82 | +33.3% |
| FY2024 | $7.36 | +25.7% |
| FY2023 | $5.86 | -28.2% |
| FY2022 | $8.16 | +40.0% |
| FY2021 | $5.83 | -29.2% |
| FY2020 | $8.23 | +12.0% |
| FY2019 | $7.34 | -28.7% |
| FY2018 | $10.30 | +23.3% |
| FY2017 | $8.35 | -50.4% |
| FY2016 | $16.83 | +80.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026